Attention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004
- PMID: 23325553
- PMCID: PMC3638065
- DOI: 10.1111/j.2047-6310.2012.00124.x
Attention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004
Abstract
What is already known about this subject: Youth with ADHD may be at increased risk for obesity. Medications used to treat ADHD can affect weight. Few studies have investigated possible gender differences in associations between ADHD and obesity.
What this study adds: Nationally representative of US youth aged 8-15 years. Height and weight were measured, and ADHD assessed by structured diagnostic interview and parent report. Associations between ADHD and obesity are reported for males and females to enable gender comparisons.
Objective: To investigate how associations between attention-deficit/hyperactivity disorder (ADHD) and obesity differ by gender and medication use in a nationally representative sample of US youth in which height and weight were measured.
Methods: Youth age 8-15 (n = 3050) studied in the National Health and Nutrition Examination Survey 2001-2004. Obesity was defined as ≥95th percentile of US body mass index-for-age reference. ADHD was determined by asking parents if child had been diagnosed and using the Diagnostic Interview Schedule for Children IV. Gender-stratified multivariable logistic regression was used to estimate odds of obesity for youth with ADHD (medicated and unmedicated) relative to youth without ADHD.
Results: Males with ADHD who were medicated had lower odds of obesity compared to males without ADHD (adjusted odds ratio [OR] = 0.42, 95% confidence interval [CI] = 0.23-0.78). Unmedicated males with ADHD were as likely as males without ADHD to be obese (adjusted OR = 1.02, 95% CI = 0.43-2.42). The odds of obesity for females taking medication for ADHD did not differ statistically from those of females without ADHD (adjusted OR = 1.21, 95% CI = 0.52-2.81). Females with ADHD not taking medication had odds of obesity 1.54 times those of females without ADHD; however, the 95% CI (0.79-2.98) was wide and not statistically significant at α = 0.05.
Conclusions: Associations between ADHD and obesity are influenced by treatment of ADHD with medication and may differ by gender. Youth with ADHD who are not treated with medication are as or more likely than youth without ADHD to be obese.
Keywords: Attention-deficit/hyperactivity disorder (ADHD); National Health and Nutrition Examination Survey (NHANES); gender differences; obesity.
© 2012 The Authors. Pediatric Obesity © 2012 International Association for the Study of Obesity.
Conflict of interest statement
Similar articles
-
Prevalence of overweight in children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorders: a chart review.BMC Pediatr. 2005 Dec 21;5:48. doi: 10.1186/1471-2431-5-48. BMC Pediatr. 2005. PMID: 16371155 Free PMC article.
-
Receipt of Medication and Behavioral Therapy Among a National Sample of School-Age Children Diagnosed With Attention-Deficit/Hyperactivity Disorder.Acad Pediatr. 2018 Apr;18(3):256-265. doi: 10.1016/j.acap.2017.10.003. Epub 2017 Oct 20. Acad Pediatr. 2018. PMID: 29061327
-
Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.J Am Acad Child Adolesc Psychiatry. 2016 Jun;55(6):479-86. doi: 10.1016/j.jaac.2016.03.011. Epub 2016 Apr 7. J Am Acad Child Adolesc Psychiatry. 2016. PMID: 27238066 Free PMC article.
-
Attention-deficit/hyperactivity disorder (ADHD) and being overweight/obesity: New data and meta-analysis.Clin Psychol Rev. 2016 Feb;43:67-79. doi: 10.1016/j.cpr.2015.11.005. Epub 2015 Dec 2. Clin Psychol Rev. 2016. PMID: 26780581 Free PMC article. Review.
-
Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.JAMA. 1998 Apr 8;279(14):1100-7. doi: 10.1001/jama.279.14.1100. JAMA. 1998. PMID: 9546570 Review.
Cited by
-
Shared Genetic Factors Contributing to the Overlap between Attention-Deficit/Hyperactivity Disorder Symptoms and Overweight/Obesity in Swedish Adolescent Girls and Boys.Twin Res Hum Genet. 2022 Dec;25(6):226-233. doi: 10.1017/thg.2022.35. Epub 2023 Jan 12. Twin Res Hum Genet. 2022. PMID: 36633106 Free PMC article.
-
Assessing causality in the association between attention-deficit/hyperactivity disorder and obesity: a Mendelian randomization study.Int J Obes (Lond). 2019 Dec;43(12):2500-2508. doi: 10.1038/s41366-019-0346-8. Epub 2019 Apr 18. Int J Obes (Lond). 2019. PMID: 31000774
-
Adult attention-deficit hyperactivity disorder and obesity: epidemiological study.Br J Psychiatry. 2013 Jul;203(1):24-34. doi: 10.1192/bjp.bp.112.123299. Epub 2013 May 9. Br J Psychiatry. 2013. PMID: 23661765 Free PMC article.
-
Associations between attention deficit hyperactivity disorder symptoms and eating behaviors in early childhood.Pediatr Obes. 2020 Jul;15(7):e12631. doi: 10.1111/ijpo.12631. Epub 2020 Mar 2. Pediatr Obes. 2020. PMID: 32119190 Free PMC article.
-
Attention-Deficit/Hyperactivity Disorder and Lifestyle-Related Behaviors in Children.PLoS One. 2016 Sep 22;11(9):e0163434. doi: 10.1371/journal.pone.0163434. eCollection 2016. PLoS One. 2016. PMID: 27658266 Free PMC article.
References
-
- Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of Attention-Deficit/Hyperactivity Disorder in a national sample of us children. Arch Pediatr Adolesc Med. 2007;161(9):857–864. - PubMed
-
- Van Cleave J, Gortmaker SL, Perrin JM. Dynamics of obesity and chronic health conditions among children and youth. JAMA. 2010;303(7):623–630. - PubMed
-
- Buka SL, Monuteaux M, Earls F. Epidemiology of child and adolescent mental disorders. In: Tsuang MT, Tochen M, editors. Textbook in Psychiatric Epidemiology. 2. Wiley-Liss, Inc; New York: 2002.
-
- Rappley MD. Clinical practice. Attention Deficit-Hyperactivity Disorder. N Engl J Med. 2005;352(2):165–173. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical